%0 Journal Article
%T Impact of renal function on mid-term outcomes in heart failure patients treated with tolvaptan
%A Hiroaki Hirase
%A Kenshi Hayashi
%A Kensuke Fujioka
%A Masa-aki Kawashiri
%A Masakazu Yamagishi
%A Masato Yamaguchi
%A Noboru Fujino
%A Sumio Mizuno
%A Takahiko Aoyama
%A Takao Matsui
%A Taro Ichise
%J Archive of "Therapeutic Advances in Cardiovascular Disease".
%D 2019
%R 10.1177/1753944718819064
%X Although tolvaptan, an electrolyte-free water diuretic for congestive heart failure (HF), is reported to have no effect on long-term mortality or HF-related morbidity, there may exist some subgroups of patients who may receive beneficial effect of tolvaptan. The purpose of this study was to identify clinical factors associated with mid-term effect of tolvaptan on clinical outcomes of patients who discharged after acute HF
%K Cox proportional hazards model
%K diuretics
%K glomerular filtration rate
%K heart failure
%K tolvaptan
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6348497/